Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added the term Hepatocellular carcinoma and a new 'Genetic and Rare Diseases Information Center' resource; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:02:32.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:29:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study now lists two locations, including Parkland Health & Hospital System in Dallas, TX; this augments the previously listed single-location site.
    Difference
    0.4%
    Check dated 2026-02-18T04:52:05.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding status notice and the previous Revision: v3.4.1 from the page.
    Difference
    0.4%
    Check dated 2026-02-11T03:10:59.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Page now shows a government funding lapse notice with the NIH Clinical Center's operating status. The revision label has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:50:55.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with capitalization tweaks to 'No FEAR Act Data' and a new site revision note 'Revision: v3.4.0'.
    Difference
    0.3%
    Check dated 2026-01-28T00:35:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.